2023
7
Lee CM, Kim M, Park SW, Kang CK, Choe PG, Kim NJ, Jo HJ, Shin HM, Lee CH, Kim HR, Park WB, Oh MD.
​
Infect Dis (Lond) . 2023 Nov 2:1-12. doi: 10.1080/23744235.2023.2276784
6
Kim IS, Kang CK, Lee SJ, Lee CH, Kim M, Seo C, Kim G, Lee S, Park KS, Chang E, Jung J, Song KH, Choe PG, Park WB, Kim ES, Bin Kim H, Kim NJ, Oh MD, Lee JE, Shin HM, Kim HR.
​
​
J Med Virol . 2023 Nov;95(11):e29199. doi: 10.1002/jmv.29199.
5
Han HS, Ahn E, Park ES, Huh T, Choi S, Kwon Y, Choi BH, Lee J, Choi YH, Jeong YL, Lee GB, Kim M, Seong JK, Shin HM, Kim HR, Moon MH, Kim JK, Hwang GS, Koo SH.
Impaired BCAA catabolism in adipose tissues promotes age-associated metabolic derangement.
Nat Aging. 2023. https://doi: 10.1038/s43587-023-00460-8.
4
Lee CM, Kim M, Kang CK, Choe PG, Kim NJ, Bang H, Cho T, Shin HM, Kim HR, Park WB, Oh MD.
Different degree of cytokinemia and T-cell activation according to serum IL-6 levels in critical COVID-19.
Front Immunol. 2023. https://doi: 10.3389/fimmu.2023.1110874.
3
2
Lee CM, Choe PG, Kang CK, Lee E, Song KH, Bang JH, Kim ES, Kim HB, Kim NJ, Kim HR, Kim Y, Lee CH, Shin HM, Park SW, Park WB, Oh MD.
Front Immunol. 2023. https://doi: 10.3389/fimmu.2023.1106664.
1
Kang CK, Kim MG, Park SW, Kim YW, Lee CM, Choe PG, Park WB, Kim NJ, Kim M, Lee S, Kim IS, Lee CH, Shin HM, Kim HR, Oh MD.
J Med. Viral. 2023. https://ddoi: 10.1002/jmv.28558.
2022
8
Kwon YJ, Seo EB, Jeong AJ, Lee SH, Noh KH, Lee S, Cho CH, Lee CH, Shin HM, Kim HR, Moon HG, Ye SK.
The acidic tumor microenvironment enhances PD-L1 expression via activation of STAT3 in MDA-MB-231 breast cancer cells
BMC Cancer. 2022. https://doi: 10.1186/s12885-022-09956-9.
7
Kang CK, Shin HM, Choe PG, Park J, Hong J, Seo JS, Lee YH, Chang E, Kim NJ, Kim M, Kim YW, Kim HR, Lee CH, Seo JY, Park WB, Oh MD.
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
BMC Medicine. 2022. https://doi: 10.1186/s12916-022-02383-4.
6
Jeon YH, Lee N, Yoo J, Won S, Shin SK, Kim KH, Park JG, Kim MG, Kim HR, Oh K, Lee DS.​
Biomedicines. 2022. https://doi: 10.3390/biomedicines10040805.
5
Kang, C.K., Shin, H.M., Park, W.B., Kim HR.
​​
Cell Mol Immunol. (IF: 11.530) 2022. https://doi.org/10.1038/s41423-022-00857-2
4
Chang Kyung Kang#, Minji Kim#, Jisu Hong#, Gwanghun Kim, Soojin Lee, Pyoeng Gyun Choe, Nam Joong Kim, Ik Soo Kim, Jun-Young Seo, Daesub Song, Dong-Sup Lee, Hyun Mu Shin, Chang-Han Lee*, Wan Beom Park*, Hang-Rae Kim* and Myoung-don Oh
# Co-first author, *Co-corresponding author
​
Distinctive immune response after one-year post COVID-19 according to the severity
​
Frontiers in Immunology (IF: 7.561), 21 March 2022, vol 13, 830433
3
Kim G, Shin HM, Kim HR, Kim Y
​​
Effects of host and pathogenicity on mutation rates in avian influenza A viruses.
Virus Evol. (IF: 7.989) 2022 Feb 21;8(1):veac013. doi: 10.1093/ve/veac013. eCollection 2022. PMID: 35295747
2
Jeong HS, Lee DH, Kim SH, Lee CH, Shin HM, Kim HR, Cho CH
​​
​​
Oncogene (IF: 9.867), 2022 Mar;41(11):1634-1646. doi: 10.1038/s41388-022-02207-y. PMID: 35094008
1
Noh KH, Lee SH, Lee H, Jeong AJ, Kim KO, Shin HM, Kim HR, Park MJ, Park JB, Lee J, Ye SK*
Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma
​​
Transl Oncol. (IF:4.243) 2022 Jan ;15(1):101255. PMID: 34742152
2021
5
Cho Y, Kim HS, Kang D, Kim H, Lee N, Yun J, Kim YJ, Lee KM, Kim JH, Kim HR, Hwang YI, Jo CH, Kim JH.
CTRP3 exacerbates tendinopathy by dysregulating tendon stem cell differentiation and altering extracellular matrix composition.
​
Science Advances. 2021 Nov 19;7(47): eabg6069. PMID: 34797714
4
Kang CK, Kim M, Lee S, Kim G, Choe PG, Park WB, Kim NJ, Lee CH, Kim IS, Jung K, Lee DS, Shin HM, HR Kim, M Oh.
Longitudinal Analysis of Human Memory T-Cell Response according to the Severity of Illness up to 8 Months after SARS-CoV-2 Infection.
J Infect Dis. 2021 Mar 23;jiab159. PMID: 33755725, corresponding author
3
Shin HM, Kim G, Kim S, Sim JH, Choi J, Kim M, Kwon M, Ye SK, Lee DS, Cho SW, Kim ST, Lee J, Kim HR.
Chromatin accessibility of circulating CD8+ T cells predicts treatment response to PD-1 blockade in patients with gastric cancer.
Nat Commun. 2021 Feb 12;12(1):975. PMID: 33579944
2
Yoon KJ, Ahn A, Park SH, Kwak SH, Kwak SE, Lee W, Yang YR, Kim M, Shin HM, Kim HR, Moon HY.
Exercise reduces metabolic burden while altering the immune system in aged mice.
Aging (Albany NY). 2021 Jan 6;13(1):1294-1313. PMID: 33406502
1
Li X, Jeon YH, Kown N, Park JG, Guo T, Kim HR, Huang JD, Lee DS, Yoon J.
In Vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer.
Biomaterials 2021 Jan;266:120430. PMID: 33011679
2023
5
Han HS, Ahn E, Park ES, Huh T, Choi S, Kwon Y, Choi BH, Lee J, Choi YH, Jeong YL, Lee GB, Kim M, Seong JK, Shin HM, Kim HR, Moon MH, Kim JK, Hwang GS, Koo SH.
Impaired BCAA catabolism in adipose tissues promotes age-associated metabolic derangement.
Nat Aging. 2023. https://doi: 10.1038/s43587-023-00460-8.
4
Lee CM, Kim M, Kang CK, Choe PG, Kim NJ, Bang H, Cho T, Shin HM, Kim HR, Park WB, Oh MD.
Different degree of cytokinemia and T-cell activation according to serum IL-6 levels in critical COVID-19.
Front Immunol. 2023. https://doi: 10.3389/fimmu.2023.1110874.
3
2
Lee CM, Choe PG, Kang CK, Lee E, Song KH, Bang JH, Kim ES, Kim HB, Kim NJ, Kim HR, Kim Y, Lee CH, Shin HM, Park SW, Park WB, Oh MD.
Front Immunol. 2023. https://doi: 10.3389/fimmu.2023.1106664.
1
Kang CK, Kim MG, Park SW, Kim YW, Lee CM, Choe PG, Park WB, Kim NJ, Kim M, Lee S, Kim IS, Lee CH, Shin HM, Kim HR, Oh MD.
J Med. Viral. 2023. https://ddoi: 10.1002/jmv.28558.
2022
8
Kwon YJ, Seo EB, Jeong AJ, Lee SH, Noh KH, Lee S, Cho CH, Lee CH, Shin HM, Kim HR, Moon HG, Ye SK.
The acidic tumor microenvironment enhances PD-L1 expression via activation of STAT3 in MDA-MB-231 breast cancer cells
BMC Cancer. 2022. https://doi: 10.1186/s12885-022-09956-9.
7
Kang CK, Shin HM, Choe PG, Park J, Hong J, Seo JS, Lee YH, Chang E, Kim NJ, Kim M, Kim YW, Kim HR, Lee CH, Seo JY, Park WB, Oh MD.
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
BMC Medicine. 2022. https://doi: 10.1186/s12916-022-02383-4.
6
Jeon YH, Lee N, Yoo J, Won S, Shin SK, Kim KH, Park JG, Kim MG, Kim HR, Oh K, Lee DS.​
Biomedicines. 2022. https://doi: 10.3390/biomedicines10040805.
5
Kang, C.K., Shin, H.M., Park, W.B., Kim HR.
​​
Cell Mol Immunol. (IF: 11.530) 2022. https://doi.org/10.1038/s41423-022-00857-2
4
Chang Kyung Kang#, Minji Kim#, Jisu Hong#, Gwanghun Kim, Soojin Lee, Pyoeng Gyun Choe, Nam Joong Kim, Ik Soo Kim, Jun-Young Seo, Daesub Song, Dong-Sup Lee, Hyun Mu Shin, Chang-Han Lee*, Wan Beom Park*, Hang-Rae Kim* and Myoung-don Oh
# Co-first author, *Co-corresponding author
​
Distinctive immune response after one-year post COVID-19 according to the severity
​
Frontiers in Immunology (IF: 7.561), 21 March 2022, vol 13, 830433
3
Kim G, Shin HM, Kim HR, Kim Y
​​
Effects of host and pathogenicity on mutation rates in avian influenza A viruses.
Virus Evol. (IF: 7.989) 2022 Feb 21;8(1):veac013. doi: 10.1093/ve/veac013. eCollection 2022. PMID: 35295747
2
Jeong HS, Lee DH, Kim SH, Lee CH, Shin HM, Kim HR, Cho CH
​​
​​
Oncogene (IF: 9.867), 2022 Mar;41(11):1634-1646. doi: 10.1038/s41388-022-02207-y. PMID: 35094008
1
Noh KH, Lee SH, Lee H, Jeong AJ, Kim KO, Shin HM, Kim HR, Park MJ, Park JB, Lee J, Ye SK*
Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma
​​
Transl Oncol. (IF:4.243) 2022 Jan ;15(1):101255. PMID: 34742152
2021
5
Cho Y, Kim HS, Kang D, Kim H, Lee N, Yun J, Kim YJ, Lee KM, Kim JH, Kim HR, Hwang YI, Jo CH, Kim JH.
CTRP3 exacerbates tendinopathy by dysregulating tendon stem cell differentiation and altering extracellular matrix composition.
​
Science Advances. 2021 Nov 19;7(47): eabg6069. PMID: 34797714
4
Kang CK, Kim M, Lee S, Kim G, Choe PG, Park WB, Kim NJ, Lee CH, Kim IS, Jung K, Lee DS, Shin HM, HR Kim, M Oh.
Longitudinal Analysis of Human Memory T-Cell Response according to the Severity of Illness up to 8 Months after SARS-CoV-2 Infection.
J Infect Dis. 2021 Mar 23;jiab159. PMID: 33755725, corresponding author
3
Shin HM, Kim G, Kim S, Sim JH, Choi J, Kim M, Kwon M, Ye SK, Lee DS, Cho SW, Kim ST, Lee J, Kim HR.
Chromatin accessibility of circulating CD8+ T cells predicts treatment response to PD-1 blockade in patients with gastric cancer.
Nat Commun. 2021 Feb 12;12(1):975. PMID: 33579944
2
Yoon KJ, Ahn A, Park SH, Kwak SH, Kwak SE, Lee W, Yang YR, Kim M, Shin HM, Kim HR, Moon HY.
Exercise reduces metabolic burden while altering the immune system in aged mice.
Aging (Albany NY). 2021 Jan 6;13(1):1294-1313. PMID: 33406502
1
Li X, Jeon YH, Kown N, Park JG, Guo T, Kim HR, Huang JD, Lee DS, Yoon J.
In Vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer.
Biomaterials 2021 Jan;266:120430. PMID: 33011679
6
Jeon YH, Lee N, Yoo J, Won S, Shin SK, Kim KH, Park JG, Kim MG, Kim HR, Oh K, Lee DS.​
Biomedicines. 2022. https://doi: 10.3390/biomedicines10040805.
5
Kang, C.K., Shin, H.M., Park, W.B., Kim HR.
​​
Cell Mol Immunol. (IF: 11.530) 2022. https://doi.org/10.1038/s41423-022-00857-2
4
Chang Kyung Kang#, Minji Kim#, Jisu Hong#, Gwanghun Kim, Soojin Lee, Pyoeng Gyun Choe, Nam Joong Kim, Ik Soo Kim, Jun-Young Seo, Daesub Song, Dong-Sup Lee, Hyun Mu Shin, Chang-Han Lee*, Wan Beom Park*, Hang-Rae Kim* and Myoung-don Oh
# Co-first author, *Co-corresponding author
​
Distinctive immune response after one-year post COVID-19 according to the severity
​
Frontiers in Immunology (IF: 7.561), 21 March 2022, vol 13, 830433
3
Kim G, Shin HM, Kim HR, Kim Y
​​
Effects of host and pathogenicity on mutation rates in avian influenza A viruses.
Virus Evol. (IF: 7.989) 2022 Feb 21;8(1):veac013. doi: 10.1093/ve/veac013. eCollection 2022. PMID: 35295747
2
Jeong HS, Lee DH, Kim SH, Lee CH, Shin HM, Kim HR, Cho CH
​​
​​
Oncogene (IF: 9.867), 2022 Mar;41(11):1634-1646. doi: 10.1038/s41388-022-02207-y. PMID: 35094008
1
Noh KH, Lee SH, Lee H, Jeong AJ, Kim KO, Shin HM, Kim HR, Park MJ, Park JB, Lee J, Ye SK*
Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma
​​
Transl Oncol. (IF:4.243) 2022 Jan ;15(1):101255. PMID: 34742152
7
Kang CK, Shin HM, Choe PG, Park J, Hong J, Seo JS, Lee YH, Chang E, Kim NJ, Kim M, Kim YW, Kim HR, Lee CH, Seo JY, Park WB, Oh MD.
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
BMC Medicine. 2022. https://doi: 10.1186/s12916-022-02383-4.
2021
5
Cho Y, Kim HS, Kang D, Kim H, Lee N, Yun J, Kim YJ, Lee KM, Kim JH, Kim HR, Hwang YI, Jo CH, Kim JH.
CTRP3 exacerbates tendinopathy by dysregulating tendon stem cell differentiation and altering extracellular matrix composition.
​
Science Advances. 2021 Nov 19;7(47): eabg6069. PMID: 34797714
4
Kang CK, Kim M, Lee S, Kim G, Choe PG, Park WB, Kim NJ, Lee CH, Kim IS, Jung K, Lee DS, Shin HM, HR Kim, M Oh.
Longitudinal Analysis of Human Memory T-Cell Response according to the Severity of Illness up to 8 Months after SARS-CoV-2 Infection.
J Infect Dis. 2021 Mar 23;jiab159. PMID: 33755725, corresponding author
3
Shin HM, Kim G, Kim S, Sim JH, Choi J, Kim M, Kwon M, Ye SK, Lee DS, Cho SW, Kim ST, Lee J, Kim HR.
Chromatin accessibility of circulating CD8+ T cells predicts treatment response to PD-1 blockade in patients with gastric cancer.
Nat Commun. 2021 Feb 12;12(1):975. PMID: 33579944
2
Yoon KJ, Ahn A, Park SH, Kwak SH, Kwak SE, Lee W, Yang YR, Kim M, Shin HM, Kim HR, Moon HY.
Exercise reduces metabolic burden while altering the immune system in aged mice.
Aging (Albany NY). 2021 Jan 6;13(1):1294-1313. PMID: 33406502
1
Li X, Jeon YH, Kown N, Park JG, Guo T, Kim HR, Huang JD, Lee DS, Yoon J.
In Vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer.
Biomaterials 2021 Jan;266:120430. PMID: 33011679